BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35909471)

  • 1. Characterization of Butyrate-Resistant Colorectal Cancer Cell Lines and the Cytotoxicity of Anticancer Drugs against These Cells.
    Nittayaboon K; Leetanaporn K; Sangkhathat S; Roytrakul S; Navakanitworakul R
    Biomed Res Int; 2022; 2022():6565300. PubMed ID: 35909471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells.
    Kim HJ; An J; Ha EM
    J Microbiol; 2022 Jan; 60(1):100-117. PubMed ID: 34964946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrate-mediated acquisition of chemoresistance by human colon cancer cells.
    Kang HR; Choi HG; Jeon CK; Lim SJ; Kim SH
    Oncol Rep; 2016 Aug; 36(2):1119-26. PubMed ID: 27277338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray Analysis of Gene Expression Involved in Butyrate-Resistant Colorectal Carcinoma HCT116 Cells.
    Khonthun C; Saikachain N; Popluechai S; Kespechara K; Hiranyakas A; Srikummool M; Surangkul D
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1739-1746. PubMed ID: 32592372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effect of metformin on butyrate-resistant PMF-K014 colorectal cancer spheroid cells.
    Nittayaboon K; Leetanaporn K; Sangkhathat S; Roytrakul S; Navakanitworakul R
    Biomed Pharmacother; 2022 Jul; 151():113214. PubMed ID: 35676792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.
    Chiaro C; Lazarova DL; Bordonaro M
    Biochem Biophys Res Commun; 2012 Nov; 428(1):121-6. PubMed ID: 23063976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
    Chang CC; Kao WY; Liu CY; Su HH; Kan YA; Lin PY; Ku WC; Chang KW; Yang RN; Huang CJ
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35417036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response.
    Fung KY; Brierley GV; Henderson S; Hoffmann P; McColl SR; Lockett T; Head R; Cosgrove L
    J Proteome Res; 2011 Apr; 10(4):1860-9. PubMed ID: 21235278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate-mediated Resistance to Trichostatin A Accompanied by Elevated Expression of Glucose Transporter 3 (GLUT3) in Human Colorectal Carcinoma HCT116 Cells.
    Khonthun C; Surangkul D
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4085-4092. PubMed ID: 38156841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
    Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
    Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
    Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
    BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression.
    He Y; Ling Y; Zhang Z; Mertens RT; Cao Q; Xu X; Guo K; Shi Q; Zhang X; Huo L; Wang K; Guo H; Shen W; Shen M; Feng W; Xiao P
    Redox Biol; 2023 Sep; 65():102822. PubMed ID: 37494767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cells.
    Fung KY; Ooi CC; Lewanowitsch T; Tan S; Tan HT; Lim TK; Lin Q; Williams DB; Lockett TJ; Cosgrove LJ; Chung MC; Head RJ
    J Proteome Res; 2012 Dec; 11(12):6019-29. PubMed ID: 23057685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
    Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE; Elder DJ; Paraskeva C
    Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate Inhibits Deoxycholic-Acid-Resistant Colonic Cell Proliferation via Cell Cycle Arrest and Apoptosis: A Potential Pathway Linking Dietary Fiber to Cancer Prevention.
    Zeng H; Safratowich BD; Wang TTY; Hamlin SK; Johnson LK
    Mol Nutr Food Res; 2020 Apr; 64(8):e1901014. PubMed ID: 32003143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
    Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
    Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrate Inhibits Indices of Colorectal Carcinogenesis via Enhancing α-Ketoglutarate-Dependent DNA Demethylation of Mismatch Repair Genes.
    Sun X; Zhu MJ
    Mol Nutr Food Res; 2018 May; 62(10):e1700932. PubMed ID: 29577594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
    Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.